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Hypochlorous acid (HOCl), the active ingredient in
household bleach, is an effective antimicrobial pro-
duced by the mammalian host defense to kill invad-
ing microorganisms. Despite the widespread use of
HOCl, surprisingly little is known about its mode of
action. In this study, we demonstrate that low molar
ratios of HOCl to protein cause oxidative protein un-
folding in vitro and target thermolabile proteins for ir-
reversible aggregation in vivo. As a defense mecha-
nism, bacteria use the redox-regulated chaperone
Hsp33, which responds to bleach treatment with
the reversible oxidative unfolding of its C-terminal
redox switch domain. HOCl-mediated unfolding
turns inactive Hsp33 into a highly active chaperone
holdase, which protects essential Escherichia coli
proteins against HOCl-induced aggregation and in-
creases bacterial HOCl resistance. Our results sub-
stantially improve our molecular understanding
about HOCl’s functional mechanism. They suggest
that the antimicrobial effects of bleach are largely
based on HOCl’s ability to cause aggregation of es-
sential bacterial proteins.
INTRODUCTION
The accumulation of reactive oxygen species (ROS), a condition
termed oxidative stress, is associated with a variety of different
human diseases (Aliev et al., 2002). ROS also serve beneficial
roles for mammals during host defense, when macrophages
and neutrophils produce high concentrations of hydrogen perox-
ide (H2O2), superoxide (O2
), and hypochlorous acid (HOCl) to
kill invading microorganisms (Miller and Britigan, 1997).
The heat shock protein Hsp33 is a member of a highly con-
served family of molecular chaperones that specifically protects
bacteria against the lethal consequences of oxidative stress at
elevated temperatures (i.e., oxidative heat stress) (Winter et al.,
2005). Recent in vitro studies confirmed that Hsp33 utilizes adual stress-sensing mechanism that responds to the simulta-
neous presence of oxidants (e.g., H2O2) and mild protein unfold-
ing conditions (e.g., elevated temperatures or 1 M guanidinium-
hydrochloride) with the activation of its chaperone function (Ilbert
et al., 2007). H2O2-sensing occurs through a four-cysteine zinc
center, while elevated temperatures are sensed by an adjacent
linker region whose conformation appears to control the reactiv-
ity or accessibility of two of Hsp33’s four redox-active cysteines,
Cys232 and Cys234 (Ilbert et al., 2007; Leichert et al., 2008). Expo-
sure of Hsp33 to oxidative heat stress leads to the consecutive
formation of both intramolecular disulfide bonds and zinc(II)
release (Graumann et al., 2001). These posttranslational modifi-
cations cause Hsp33’s linker region and zinc-binding domain
to adopt a natively unfolded structure (Graf et al., 2004; Ilbert
et al., 2007). Large hydrophobic surfaces, which are the likely
binding sites for unfolded proteins, become exposed, and Hsp33
assembles into the dimeric, fully active chaperone (Graf et al.,
2004; Ilbert et al., 2007).
Hsp33’s activation requires both peroxide stress and heat
stress, whereas neither peroxide treatment alone nor high tem-
peratures alone causes the activation of Hsp33 either in vitro
or in vivo (Ilbert et al., 2007; Winter et al., 2005). This makes
good physiological sense; peroxide stress itself does not cause
protein unfolding in vivo and therefore does not require addi-
tional chaperones (Ilbert et al., 2007), whereas protein unfolding
induced by elevated temperatures is effectively prevented by
ATP-dependent chaperones, such as the DnaK-system (Mayer
et al., 2001). Oxidative heat stress, however, causes protein un-
folding and simultaneously decreases cellular ATP levels, which
incapacitates ATP-dependent chaperones (Winter et al., 2005).
Activation of Hsp33’s ATP-independent chaperone function un-
der these specific stress conditions appears therefore to com-
pensate for the functional loss of ATP-dependent chaperones.
These findings helped explain the cytoprotective effects of
Hsp33 under oxidative heat stress conditions. However, these
results also raised the questions as to when and how often or-
ganisms encounter conditions that cause oxidative stress condi-
tions that lead to protein unfolding in nature. In this study, we
identified HOCl, the active ingredient of household bleach, as
a reagent that rapidly induces oxidative protein unfolding
in vitro and causes irreversible protein aggregation in vivo. This
capacity likely contributes to the highly bactericidal effect ofCell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc. 691
HOCl. Hsp33 exploits these features and becomes rapidly acti-
vated by the oxidative unfolding of its redox switch domain. It
can then effectively protect numerous essential bacterial pro-
teins against HOCl-mediated aggregation and Escherichia coli
and Vibrio cholerae cells against HOCl-induced cell death.
RESULTS
Bleach—A Potent Activator of Hsp33’s Chaperone
Function
The predominant source of exogenous oxidative and nitrosative
stress for pathogenic bacteria is generated by cells of the innate
immune system, which release high concentrations of ROS into
the phagosome to kill the engulfed bacteria (Miller and Britigan,
1997). One protein that has been shown to protect microorgan-
isms against H2O2-mediated oxidative stress is the highly con-
served redox-regulated chaperone Hsp33 (Winter et al., 2005).
This protection is, however, restricted to peroxide stress at
heat shock temperatures. To investigate what physiologically
relevant reactive oxygen or nitrogen species might cause the
activation of Hsp33 also at nonstress temperatures, we incu-
bated reduced, inactive Hsp33 (Hsp33red) with either H2O2, hy-
pochlorous acid (HOCl), or the nitric oxide donor diethylamine
Figure 1. HOCl—A Potent Activator of Hsp33’s Chaperone
Function
A. 50 mM Hsp33red was incubated in the presence of 2 mM H2O2, 2 mM
DEANO or 500 mM HOCl at either 30C or 43C. After 20 min (HOCl) or
3 hr (DEANO, H2O2) of incubation, the oxidants were removed, and the in-
fluence of Hsp33 (0.3 mM) on the aggregation of 75 nM chemically dena-
tured citrate synthase (CS) was determined at 30C. The light-scattering
signal of CS in the absence of Hsp33 was defined as 0%, whereas com-
plete suppression of CS aggregation was set to 100%.
B. 50 mM Hsp33red was incubated with 2 mM H2O2 (open circles) or
500 mM HOCl (open triangles) at 30C or with 2 mM H2O2 at 43C (filled
circles). At various time points, aliquots were removed and the influence
of Hsp33 on the aggregation of CS was determined as described above.
Activation of Hsp33red with 500 mM HOCl at 43
C was completed within
the mixing time of the experiment.
NONOate (DEANO) at both 30C and 43C and analyzed
Hsp33’s functional activity as a molecular chaperone. As
shown previously, H2O2 significantly activated Hsp33 only
when the treatment was performed at elevated temperatures
(Figure 1A) (Ilbert et al., 2007). Simultaneous presence of ox-
idants and mild unfolding conditions appear to be required
for the formation of Hsp33’s second disulfide bond between
Cys232 and Cys234, which has been suggested to be the rate-
determining step in Hsp33’s activation process (Leichert
et al., 2008). Similar results were obtained upon incubation
of Hsp33red with DEANO, which caused significant activation
at 43C but not at 30C (Figure 1A). This result indicated that,
like H2O2, DEANO is unable to activate Hsp33 unless it is
combined with protein-unfolding conditions. In contrast,
however, treatment of Hsp33 with HOCl fully activated
Hsp33 at both 30C and 43C. These results suggested
that HOCl is an oxidant that might alleviate Hsp33’s need
for elevated temperatures during its activation process.
To determine the minimum HOCl concentration that can effec-
tively activate Hsp33 in vitro and possibly in vivo, we incubated
various concentrations of Hsp33red (5–50 mM) with increasing
concentrations of HOCl and tested its chaperone activity (see
Figure S1A available online; data not shown). We found that, in-
dependent of the absolute HOCl concentration, a 10:1 molar ra-
tio of HOCl to Hsp33 was sufficient to activate Hsp33. To inves-
tigate how rapidly HOCl activates Hsp33 in vitro, we then
incubated Hsp33red with a 10-fold molar excess of HOCl at var-
ious temperatures and determined the activation kinetics of
Hsp33 (Figure 1B). At both 43C and 30C, the HOCl-mediated
activation of Hsp33 was completed within the mixing time of
the experiment (T1/2 < 1 min). This result was in stark contrast
to the activation of Hsp33 in H2O2, which proceeded with an ap-
parent half time of more than 20 min at 43C and reached less
than 10% final activity upon incubation at 30C. Moreover,
although equally fast activation kinetics were obtained when
10-fold lower concentrations of both Hsp33 and HOCl were
used (i.e., 5 mM Hsp33 and 50 mM HOCl) (data not shown), the
rate of H2O2-mediated activation at 43
C was strictly dependent
on the absolute H2O2 concentration (Figure S1B). Further reduc-
tion of the incubation temperature decreased HOCl-mediated
activation kinetics, but even at 5C, Hsp33 was still found to692 Cell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc.
be fully activated within 60 min of incubation (data not shown).
These results revealed that HOCl is a very potent activator of
Hsp33 that rapidly converts reduced, inactive Hsp33 into its ox-
idized, active conformation without the additional need of ele-
vated temperatures or chemical denaturants.
HOCl Causes Oxidative Unfolding of Hsp33’s
Redox Switch Domain
To begin to understand how HOCl-induced activation of Hsp33
can occur so rapidly even under nonstress temperatures, we
monitored the redox status of the two proximal cysteines,
Cys232 and Cys234, whose formation appears to be rate limiting
for Hsp33’s activation. We used our recently developed OxICAT
technique to precisely determine the kinetics of oxidative thiol
modifications at distinct cysteines in proteins (Leichert et al.,
2008). OxICAT is based on a differential thiol modification princi-
ple, in which reduced cysteines in a protein are labeled with the
isotopically light 12C-ICAT reagent, whereas oxidized cysteines
are, upon their reduction, labeled with the 9 Da heavier, isotopi-
cally heavy 13C-ICAT reagent. Upon peptide digestion, mass
spectrometry (MS) and MS/MS analysis are conducted. Pep-
tides that contained originally oxidized cysteines will be labeled
with 13C-ICAT and will reveal mass peaks that are exactly 9 Da or
multiples of 9 Da higher than the corresponding peptides that
harbored originally reduced cysteines. Because the peptides
are chemically identical, the precise ratios of reduced and oxi-
dized peptide species can then be determined from the height
of the respective mass peaks (Leichert et al., 2008).
We compared the mass spectra of Hsp33’s tryptic peptide
aa232–236 containing Cys232 and Cys234 in OxICAT-treated
Hsp33red and Hsp33 that was treated with a 10-fold molar ex-
cess of HOCl for either 2 min (Figure 2A) or 20 min (data not
shown) at 30C. In Hsp33red, the majority of peptide aa232–
236 was labeled with two light 12C-ICAT molecules (m/zobs =
1023.46), confirming that both thiol groups are reduced
(Figure 2A). Within 2 min of incubation in HOCl at 30C, however,
we observed a near complete shift of this peptide to the 18 Da
heavier form (m/zobs = 1041.55) (Figure 2A). In contrast, incuba-
tion for60 min in 2 mM H2O2 at 43C was necessary to achieve
a similar shift (Leichert et al., 2008). These results demonstrated
that HOCl is indeed capable of rapidly oxidizing the two crucial
cysteines in Hsp33, even under non-heat shock conditions. Be-
cause the ICAT-labeled peptide containing the second pair of
cysteines (Cys265/Cys268) is not detectable in the MS analysis
(Leichert et al., 2008), we performed thiol-trapping experiments
using iodoacetamide combined with tryptic digest and MS/MS
analysis to analyze their thiol status. As expected, we found
that the cysteines are fully oxidized in both H2O2- and HOCl-
treated Hsp33 (data not shown). In agreement with these
results, electrospray mass spectrometry (ESI-MS) of full-length,
nonlabeled Hsp33HOCl showed a predominant mass peak at
32,774.6 ± 3 Da, which is consistent with the expected molecular
mass of 32,774.8 for Hsp33 containing two intramolecular disul-
fide bonds (Figure 2B). These results confirmed that HOCl treat-
ment of Hsp33 at nonstress temperatures induces the formation
of both disulfide bonds in Hsp33 and activates the chaperone.
To assess changes in the secondary structure and hydropho-
bicity of Hsp33HOCl, circular dichroism (CD) spectroscopy andbis-ANS binding studies were performed. We found that
Hsp33HOCl showed major structural rearrangements and expo-
sure of hydrophobic surfaces, which are very similar to Hsp33
that was activated by H2O2 at 43
C (Hsp33H2O2-43C) (Figures
S2A and S2B). Analytical ultracentrifugation sedimentation
velocity experiments further agreed with these findings and re-
vealed that Hsp33HOCl sediments in a monomer-dimer equilib-
rium with a Kd for dimerization of 0.57 mM (data not shown).
This is nearly identical to the previously determined Kd of
Figure 2. HOCl—Activation by Disulfide Bond Formation
A. The thiol status of tryptic peptide aa232–236 of Hsp33red or Hsp33HOCl that
was oxidized for 2 min with a 10-fold molar excess of HOCl was analyzed using
OxICAT. The aa232–236 peptide has an expected m/z-value of 1023.46 in the
reduced form, a 9 Da higher m/z-value of 1032.50 in the partially oxidized, and
an 18 Da higher m/z-value of 1041.55 in the fully oxidized form.
B. Nano-ESI-MS of Hsp33HOCl after 20 min of oxidation using a 10-fold molar
excess of HOCl. The deconvoluted mass spectrum reveals a predominant
mass peak at 32,774.6 ± 2 Da. Very similar mass spectra were obtained for
Hsp33HOCl that was oxidized for 2 min instead.Cell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc. 693
Hsp33H2O2-43C (Kd = 0.59 mM) (Graumann et al., 2001). These
studies contradicted our previous model, which proposed that
Hsp33’s dimerization process might be the basis for Hsp33’s un-
usual temperature dependence (Graumann et al., 2001). Instead,
they demonstrated that once disulfide bond formation occurred,
native unfolding of Hsp33’s C terminus, dimerization, and activa-
tion of Hsp33 can take place also at low temperatures.
HOCl-Induced Activation of Hsp33 Is Reversible
by Thiol Reductants In Vitro
In vitro activation of Hsp33 has so far been successful only for
Hsp33 preparations that have been simultaneously treated
with thiol oxidants and protein-unfolding conditions (Ilbert
et al., 2007). To investigate whether HOCl-mediated activation
of Hsp33 proceeds via thiol oxidation that is directly thermody-
namically linked to protein unfolding or whether it involves addi-
tional side chain modifications that lower Hsp33’s overall stabil-
ity, we tested the dithiothreitol (DTT)–reversibility of Hsp33’s
activation. In contrast to oxidative modifications of non–thiol-
containing amino acids, which are either irreversible (i.e., dityro-
sine) or require specialized reductants (i.e., methionine sulfoxide)
(Boschi-Muller et al., 2008), most oxidative thiol modifications
such as disulfide bonds are fully reversible upon treatment with
Figure 3. HOCl-Mediated Activation of Hsp33 Is Reversible
A. 5 mM Hsp33HOCl was incubated with 5 mM DTT and 5 mM zinc at 30
C.
At defined time points, aliquots of the Hsp33HOCl0DTT preparation were
removed and tested for either chaperone activity (filled circles) as de-
scribed in Figure 1 or were TCA-precipitated to conduct AMS thiol-trap-
ping experiments (inset). AMS is a 490 Da thiol-specific molecule that co-
valently modifies free thiol groups. Differences in the thiol oxidation status
are reflected by mobility differences of the proteins on 14% SDS-PAGE.
B. 50 mM inactivated Hsp33HOCl0DTT was incubated in the presence of
2 mM H2O2 at 43
C. Aliquots were removed at various time points, and
the influence of Hsp33 on the aggregation of CS was determined as de-
scribed in the legend of Figure 1. Inset: 50 mM inactive Hsp33red was ac-
tivated with HOCl, subsequently inactivated with DTT, and reoxidized with
either 500 mM HOCl at 30C or 2 mM H2O2 at 43C or 30C. Activity mea-
surements were performed after 3 hr of incubation as described above.
thiol reductants such as DTT. We, therefore, incubated
Hsp33HOCl with DTT at 30
C and tested its thiol status and
chaperone activity over time. Incubation with DTT rapidly re-
stored the reduced thiol status of Hsp33 (Figure 3A, inset),
and caused the time-dependent inactivation of Hsp33’s
chaperone function (Figure 3A). That thiol reduction pre-
cedes the rather slow inactivation of Hsp33’s chaperone
function has previously also been observed with H2O2-acti-
vated Hsp33 and is therefore not specific for HOCl-activated
Hsp33 (Hoffmann et al., 2004). Although it is known that inac-
tivation of Hsp33 involves the formation of reduced kineti-
cally stable Hsp33 dimers with high chaperone activity, the
precise mechanism of Hsp33’s inactivation remains still to
be elucidated. In either case, our finding that thiol-specific
reductants inactivate Hsp33HOCl suggested that thiol modifi-
cations are indeed integral to the HOCl-mediated rapid
activation of Hsp33. This result also agreed well with our
ESI-analysis of activated Hsp33HOCl, which revealed only
a minor fraction of oxidized Hsp33HOCl molecules with stable
non-thiol modifications even after 20 min of incubation in HOCl
(Figure 2B). To further exclude, however, that non-thiol modifica-
tions that are potentially unstable in ESI-MS are involved in the
rapid HOCl-mediated activation of Hsp33, we then analyzed
the re-activation of Hsp33 upon its HOCl-mediated oxidation
and subsequent reduction (Hsp33HOCL0DTT). The rationale was
that any relevant non-thiol modification should be maintained
during the DTT-treatment and would be expected to influence
the reactivation kinetics of Hsp33HOCL0DTT. Incubation of inacti-
vated Hsp33HOCL0DTT with HOCl caused full reactivation of
Hsp33 within the mixing time of the experiment (data not shown).
Reactivation with H2O2, on the other hand, was again strongly
dependent on the environmental temperature (Figure 3B, inset)
and proceeded with kinetics that were very similar to the activa-
tion kinetics observed with freshly purified and reduced Hsp33red
at 43C (compare Figure 3B with Figure 1B). Reactivation at 30C
was again very slow and incomplete, although slightly higher
reactivation yields were obtained after 3 hr of incubation
when Hsp33HOCL0DTT was used instead of freshly reduced
Hsp33. These differences in yield most likely correspond to the
minor fraction of Hsp33HOCl molecules that were irreversibly
modified by HOCl. These results ruled out the possibility that694 Cell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc.
HOCl-mediated oxidative modification of critical side chains
other than the four active site thiols are involved in the HOCl-
mediated activation mechanism of Hsp33. We therefore con-
cluded that HOCl functions primarily as a thiol oxidant in Hsp33’s
Figure 4. HOCl Induces Protein Unfolding and Aggregation
In Vitro
A. Far UV-CD spectra of 10 mM untreated GrpE (solid line), GrpE pre-
treated with a 5-fold molar excess of HOCl (dotted line), or pretreated
with a 10-fold molar excess of HOCl (dashed line) were recorded at
30C. To monitor heat shock–induced structural changes, spectra of un-
treated GrpE were recorded at 45C (DT) (dashed and dotted line).
B. Far-UV CD spectra of CS (3 mM) in the absence of oxidants (solid line) or
after 30 min incubation in the presence of 450 mM H2O2 (dotted line) or
450 mM HOCl (dashed line) were recorded at 30C. Inset: To test the influ-
ence of oxidants on CS activity, 3 mM CS was incubated with 450 mM H2O2
(square) or 450 mM HOCl either in the absence (triangles) or presence (cir-
cle) of 3mM Hsp33HOCl. Aliquots were taken and CS activity was monitored.
C. Light-scattering measurements of CS (3 mM) were performed with
450 mM H2O2 or 450 mM HOCl in the absence of presence of 3 mM
Hsp33HOCl.
activation process in vitro and that disulfide bond formation
and domain unfolding are thermodynamically linked.
HOCl Functions as General Protein-Unfolding
Reagent In Vitro
Although the effect of HOCl on purified proteins has been pre-
viously studied, most research focused on the nature of
HOCl-mediated side chain modifications in vitro (Hawkins
et al., 2003; Winterbourn and Hampton, 2008). Few studies in-
vestigated the influence of HOCl treatment on protein activity,
and only a very select number of investigations dealt with the
potential influence of low concentrations of HOCl on the fold-
ing status of proteins (Hawkins and Davies, 2005; Jayaraman
et al., 2008). Our results indicated that low HOCl-to-protein
ratios cause the unfolding of Hsp33 in vitro. To evaluate
whether this is Hsp33 specific or might represent a general ef-
fect of HOCl, we tested the influence of HOCl on the second-
ary structure of three unrelated proteins: the heat shock
protein GrpE, the disulfide oxidoreductase DsbA, and the
chaperone substrate protein citrate synthase (CS). Short-
term incubation (5–10 min) of both GrpE and DsbA in a
10-fold molar excess of HOCl caused a partial loss in the sec-
ondary structure of both proteins (Figure 4A; data not shown).
Similar results were observed with CS, albeit higher HOCl-to-
protein ratios (>50:1) were required to induce protein unfold-
ing (Figure 4B). This, however, is probably due to residual
amounts of the Tris-containing storage buffer of CS, which,
as tertiary amine, will rapidly quench HOCl. Mass spectro-
metric analysis of HOCl-treated proteins revealed oxidative
side chain modifications, including methionine oxidation.
Therefore, not surprisingly, incubation with thiol reductants
was insufficient to restore the original protein conformation,
suggesting that the oxidative modifications are either irre-
versible or require specialized reducing systems, such as
methionine sulfoxide reductases.
Interestingly, incubation of GrpE with low ratios of HOCl to
protein (5:1) resulted in conformational changes that resem-
bled those observed in heat shock–treated GrpE (Figure 4A). At
elevated temperatures, GrpE’s thermolabile sensor region un-
folds and enables GrpE to maintain the DnaK-DnaJ-GrpE com-
plex in a high-affinity binding state (Grimshaw et al., 2003). OurCell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc. 695
results suggested that low concentrations of HOCl are sufficient
to target amino acids, whose side chain modifications, as in the
case of Hsp33, will shift the equilibrium of thermolabile regions
toward the unfolded state. We concluded from these results
that HOCl has indeed general protein-unfolding properties, pre-
sumably by oxidatively modifying critical side chains in proteins.
Incubation of thermolabile CS with HOCl led to the irreversible
unfolding and the gradual inactivation of the protein (Figure 4B,
inset). Light-scattering measurements of HOCl-treated CS re-
vealed that this unfolding leads to the massive aggregation of
the protein (Figure 4C). In sharp contrast, incubation of CS with
other physiological oxidants such as H2O2 did not change the
secondary structure of CS or its activity (Figure 4B) and did not
cause any detectable protein aggregation (Figure 4C). This result
agreed well with in vivo studies, which revealed no detectable
protein aggregation in response to H2O2 treatment (Ilbert et al.,
2007).
Because the major function of chaperone holdases such as
Hsp33 is to prevent irreversible protein aggregation, we tested
whether Hsp33 protects CS against HOCl-mediated aggrega-
tion. As shown in Figure 4C, the presence of equimolar amounts
of Hsp33HOCl was sufficient to completely suppress HOCl-medi-
ated CS aggregation. Of note, very similar results were obtained
when reduced, inactive Hsp33 was preincubated with CS before
Figure 5. Hsp33 Increases HOCl Resistance of E. coli
and V. cholerae Strains
A. E. coli wild-type BB7222 (closed circles) and the hslO dele-
tion strain JW176 (open circles) were cultivated in LB medium
at 37C. Shown are the mean and standard deviation of at
least three independent experiments.
B. E. coli rpoH deletion strain BB7224 containing an empty
pBAD vector and BB7224 overexpressing Hsp33 under
pBAD control were cultivated in LB medium containing 0.4%
w/v arabinose at 30C.
C. V. cholerae O395 and the corresponding hslO deletion
strain were cultivated in LB medium at 37C. After reaching
exponential growth, the individual cultures were washed
with phosphate buffer, supplemented with the indicated
HOCl concentrations, and incubated for 20 min at 30C. Cell
viability was analyzed by preparing serial dilutions of the cul-
tures and spotting them onto LB plates. Inset: In vivo thiol sta-
tus of Hsp33. BB7222 was treated with the indicated concen-
trations of HOCl. After 10 min of stress treatment, samples
were removed, and all in vivo–reduced cysteines were modi-
fied with iodoacetamide (IAM). After TCA precipitation and
DTT reduction, the 490 Da thiol-specific molecule AMS was
used to alkylate all in vivo oxidized cysteines. Hsp33 was visu-
alized by Western blot analysis.
HOCl addition (data not shown). This result demon-
strated that Hsp33’s extremely rapid activation by
low concentrations of HOCl makes it ideally suited
to protect other proteins against HOCl-mediated
aggregation in vitro. Coprecipitation studies using
His-tagged Hsp33 confirmed that Hsp33 forms ap-
parently very stable complexes with HOCl-induced
folding intermediates of citrate synthase (data not
shown). The presence of Hsp33HOCl did not signif-
icantly influence the HOCl-mediated inactivation of
CS (Figure 4B, inset), indicating that Hsp33 does not quench the
effective HOCl concentration or otherwise delay the inactivation
of CS.
Hsp33 Null Mutants Are HOCl Sensitive
To investigate whether the observed HOCl-mediated activation
of Hsp33’s chaperone function protects E. coli against HOCl
stress, we subjected wild-type cells and cells lacking the
Hsp33-encoding gene hslO to HOCl stress for 20 min in phos-
phate buffer at 30C and analyzed their viability. As shown in
Figure 5A, the hslO deletion strain was more sensitive toward
HOCl treatment than the corresponding wild-type strain over
a range of different HOCl concentrations. Viability of the hslO de-
letion strain began to decrease at HOCl concentrations as low as
6 mM. At 8 mM HOCl, a 100-fold decrease in cell viability was ob-
served in the hslO deletion strain relative to wild-type E. coli
(Figure 5A). Analysis of the in vivo redox status of Hsp33 in
HOCl-treated wild-type E. coli cells correlated very well with
the observed phenotype (Figure 5A, inset) and showed that
treatment of cells with 6 mM HOCl shifted most of the cellular
Hsp33 population into the fully oxidized, presumably active
state. Qualitatively very similar results were obtained upon
HOCl treatment of wild-type and hslO deletion strains in MOPS
minimal medium or LB medium, except that millimolar696 Cell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc.
concentrations of HOCl were required to affect the redox state of
Hsp33 and the viability of the strains (Figures S3A and S3B). This,
however, most likely reflects the tendency of HOCl to rapidly re-
act with numerous components of the media, which substantially
lowers the effective HOCl concentration. Finally, overexpression
of Hsp33 in the chaperone-depleted DrpoH strain was found to
also significantly increase the viability of the deletion strain
(Figure 5B). This result suggested that Hsp33 is specifically
suited to protect E. coli against HOCl-induced cell death.
The Hsp33-encoding gene hslO has been identified in the ma-
jority of bacteria that have been sequenced to date. To investi-
gate whether Hsp33 protects other gram-negative bacteria
against HOCl as well, we deleted the hslO (Hsp33) gene in Vibrio
cholerae strain O395 and tested the HOCl sensitivity of both
wild-type and hslO deletion strains. We observed that the
V. cholerae hslO deletion strain was exquisitely sensitive to
HOCl stress treatment, compared with wild type (Figure 5C). At
10 mM HOCl, the viability of the hslO deletion strain was signifi-
cantly decreased relative to wild-type V. cholerae. This result indi-
cated that the highly protective function of Hsp33 toward HOCl
stress ismost likelyconserved among Hsp33-expressingbacteria.
Hsp33 Prevents HOCl-Mediated Protein Aggregation
In Vivo
Our studies demonstrated that Hsp33, a chaperone specialized
in preventing stress-induced protein aggregation, increases the
resistance of E. coli and V. cholerae toward HOCl stress. These
Figure 6. Hsp33 Protects E. coli against HOCl-
Mediated Protein Aggregation
E. coli wild-type (BB7222) and the hslO deletion strain JW176
were cultivated in LB medium at 30C until OD600 of 0.5 was
reached. Then cells were diluted 1:2 in LB medium and sup-
plemented with 6 mM HOCl. Aliquots were removed before
and 60 min after the stress treatment. Protein aggregates
were prepared as described and were analyzed using 2D gels.
results were consistent with earlier studies that
demonstrated that HOCl treatment of E. coli trig-
gers the s32-mediated heat shock response in
E. coli (Dukan et al., 1996). Because the E. coli
heat shock response is induced by the accumula-
tion of protein-unfolding intermediates (Straus
et al., 1990), this result suggested that HOCl treat-
ment might cause protein unfolding and aggrega-
tion also in vivo. The transcriptional up-regulation
of Hsp33 as a heat shock protein, in combination
with its rapid posttranslational activation as a re-
dox-sensitive chaperone, could provide large res-
ervoirs of a highly effective chaperone holdase
that protect E. coli proteins against HOCl-induced
aggregation.
To investigate the effects of HOCl treatment on
in vivo protein aggregation, and to evaluate to
what extent Hsp33 influences these processes,
we compared protein aggregation in HOCl-treated
wild-type E. coli and hslO deletion strains. We per-
formed these experiments in LB medium instead of phosphate
buffer, which allowed us to compare our results with those of
earlier experiments in which the effects of Hsp33 on the aggre-
gation of proteins under oxidative heat stress conditions (4 mM
H2O2 at 45
C) were analyzed (Winter et al., 2005). We exposed
midlogarithmic cultures of wild-type and hslO deletion strains
to 6 mM HOCl treatment (Figure S3A) and compared protein ag-
gregation before and 30 min (data not shown) and 60 min after
the HOCl treatment. As shown in Figure 6, exposure of E. coli
cells to HOCl stress for 60 min causes the accumulation of a sig-
nificant number of aggregated proteins in E. coli. Importantly,
wild-type E. coli cells expressing functional Hsp33 revealed
less protein aggregation after both 30 min (data not shown)
and 60 min, compared with Hsp33 null mutants. This result likely
explains the beneficial effect of Hsp33 expression on the HOCl
survival of E. coli. Very similar results were obtained when we
treated cell lysates with HOCl in the absence of presence or ad-
ditional Hsp33 (Figure S4). We found that the majority of proteins
that aggregate in the presence of HOCl no longer aggregate
when the lysates were supplemented with Hsp33. This result
clearly showed that Hsp33 is a molecular chaperone that is ca-
pable of preventing HOCl-induced protein aggregation.
Analysis of the in vivo substrate proteins of Hsp33 revealed the
identity of 29 individual proteins, which showed significantly re-
duced aggregation in wild-type E. coli cells, compared with
Hsp33 null mutants (Table S1). These proteins were found to ag-
gregate between 1.5-fold and up to 17-fold less in the presenceCell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc. 697
of Hsp33 than in its absence. Among the substrate proteins of
Hsp33 are enzymes of metabolic pathways (e.g., SucA, AceE,
AdhE, and SdhA), the ribosomal protein RpsA, trigger factor,
and proteins involved in protein biosynthesis (e.g., TufB, Efp,
and Tsf). Of note, many of the substrate proteins of Hsp33 are
known to be essential for the survival of E. coli (Table S1). It re-
mains now to be analyzed whether Hsp33 exerts its cytoprotec-
tive effect in HOCl-treated wild-type cells through the stabiliza-
tion of these essential E. coli proteins or through the general
reduction of potentially toxic protein aggregates.
HOCl Targets Thermolabile Proteins for Irreversible
Protein Aggregation
It is worth noting that analysis of Hsp33’s substrate proteins re-
vealed that more than 50% of the identified proteins have been
previously shown to either aggregate in heat shock–treated
dnaK-deletion strains (Mogk et al., 1999) or turn into Hsp33’s
substrate proteins under oxidative heat stress treatment (Winter
et al., 2005) (Table S1). This result was reminiscent of our in vitro
data, which suggested that HOCl-mediated oxidative modifica-
tions in thermolabile proteins might induce their unfolding. To in-
vestigate whether HOCl-mediated protein aggregation involves
indeed mostly thermolabile E. coli proteins, we decided to di-
rectly compare HOCl and heat shock–mediated protein aggre-
gation using the chaperone-depleted E. coli strain DrpoH
(BB7224). This strain, which lacks the heat shock transcription
factor 32s, contains substantially reduced levels of most molec-
ular chaperones, except GroEL, and is unable to respond to
stress conditions with the overexpression of heat shock proteins
(Mogk et al., 1999). It is therefore a well-suited strain to study the
general aggregation sensitivity of proteins in the absence of their
chaperones. To determine the potential overlap between pro-
teins that are sensitive to heat-induced and HOCl-induced pro-
tein aggregation, we treated BB7224 with either 6 mM HOCl
for 20 min or 45C for 30 min and compared the aggregated pro-
teins by 2D gel electrophoresis. This analysis revealed that nearly
80% of proteins that aggregate in response to HOCl treatment
are thermolabile (Table S2). Interestingly, we detected only
a few proteins that are specifically sensitive toward HOCl-medi-
ated protein aggregation. One of these proteins is the heat shock
protein GroEL, which has recently been shown to be highly HOCl
sensitive in vitro (Khor et al., 2004). We concluded from these re-
sults that HOCl exerts at least part of its antimicrobial effects in
E. coli by causing protein aggregation of predominantly thermo-
labile proteins.
DISCUSSION
HOCl Exerts Its Bactericidal Effects via Protein
Unfolding and Aggregation
HOCl, the active ingredient of household bleach, has numerous
industrial applications and plays important roles in host defense
as well as in a variety of diseases, including chronic inflammation
and arteriosclerosis (Heinecke, 1999). It was therefore surprising
to learn that little is known about the mechanism by which bleach
kills bacteria (Pattison and Davies, 2006). Here, we demonstrate
that (1) HOCl causes the oxidative unfolding of proteins both
in vitro and in vivo; (2) HOCl stress leads to the irreversible aggre-698 Cell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc.gation of essential proteins in bacteria, and most importantly; (3)
a molecular chaperone, whose main function is to prevent pro-
tein aggregation during stress conditions in vivo, significantly in-
creases the resistance of E. coli and other bacteria toward HOCl
stress. These results provide powerful arguments that HOCl’s
damaging effects to bacteria during host defense and disinfec-
tion are likely due to its ability to cause protein unfolding and ag-
gregation of proteins in the cell.
What makes HOCl so much more potent than most other
known oxidants? The two-electron oxidant peroxide, which is
more oxidizing than HOCl on the basis of its standard redox po-
tential (1.776 V for H2O2 versus 1.482 V for HOCl), does not
cause protein aggregation (Figures 4C and S4) and becomes
bactericidal only at very high millimolar concentrations (Britigan
et al., 1996). This suggests that the different cellular effects of
the two oxidants are not based on their thermodynamic proper-
ties but more likely are due to differences in their reaction
rates with amino acids (Lide, 1994). The reaction rates of perox-
ide with thiols, one of the very few biomolecules that H2O2 reacts
with directly, are, apart from few exceptions (i.e., H2O2 sensor
proteins), extremely slow (k2 = 2.9 M
1s1 at pH 7.4–7.6) (Imlay,
2003; Winterbourn and Hampton, 2008). HOCl, on the other
hand, reacts with free cysteines about seven orders of magni-
tudes faster (k2 = 3.0 3 10
7 M1s1 at pH 7.4) and shows high
reaction rates with numerous other amino acid side chains,
including Met, His, a-amino acids, and tryptophans (Pattison
and Davies, 2001). These high rates of reaction will enable
HOCl to oxidize residues, which are buried and might be only
transiently accessible for oxidative modifications. These consid-
erations agree well with our in vitro and in vivo data, which sug-
gest that thermolabile proteins are particularly prone to HOCl-
mediated oxidative unfolding and aggregation. Because these
proteins are in rapid equilibrium with a partially unfolded confor-
mation, bimolecular oxidation reactions that are fast enough to
compete with the refolding reaction will cause protein unfolding
and aggregation. Thermostable proteins, on the other hand,
might be targeted predominantly on surface exposed residues,
which might not affect the activity or thermodynamic stability
of the proteins.
HOCl—A Specific Activator for a Highly Specialized
Chaperone
Hsp33, a chaperone that requires oxidative unfolding for its ac-
tivation, serves as an excellent paradigm to illustrate the mech-
anistic differences between HOCl and H2O2. We have developed
a working model of Hsp33’s activation process that is based on
the thermodynamic properties of Hsp33’s linker region and the
rapid reaction rates of HOCl (Figure 7). In this model, the linker
region of Hsp33 exists in a dynamic equilibrium between the
folded and partially unfolded state. Only upon its partial unfold-
ing, the two critical, proximal cysteines (Cys232/Cys234) become
accessible for oxidation. Once oxidized, the linker region re-
mains locked in a natively unfolded conformation until reducing
conditions are restored. This is essential for dimerization and
substrate binding. At low temperatures, the equilibrium highly fa-
vors the folded state. Therefore, the bimolecular reactions of ki-
netically slow oxidants, such as H2O2 or NO, with cysteines do
not effectively compete with the unimolecular refolding reaction,
which explains why these oxidants are unable to significantly ac-
tivate Hsp33 within the time frame of the experiment. Shifting the
equilibrium to the partially unfolded state either by incubation at
elevated temperatures or low concentrations of denaturants (1 M
Gdn*HCl), however, will increase the overall oxidation rate and
cause the activation of Hsp33. On the other hand, because of
its high reaction rates with cysteine thiols, HOCl competes with
the refolding of Hsp33’s linker region even at nonstress temper-
atures and rapidly oxidizes the cysteines. Oxidation apparently
converts Hsp33’s C terminus into its natively unfolded conforma-
tion and causes the activation of Hsp33 (Figure 7).
Hsp33—A Chaperone Specialized to Protect Bacteria
against HOCl Stress
ATP-dependent molecular chaperones, such as the GroEL/ES
system or the DnaK/DnaJ/GrpE system, are central chaperone
machineries, dedicated to protecting proteins against stress-in-
duced protein aggregation (Georgopoulos, 2006; Houry, 2001).
This situation changes, however, under oxidative stress treat-
ment, when a sudden decrease in cellular ATP levels renders
those chaperone machineries devoid of their cofactor that regu-
lates substrate binding and release (Winter et al., 2005). More-
Figure 7. Hsp33—A Paradigm for HOCl’s
Oxidative Unfolding Activity
Hsp33 consists of an N-terminal domain (blue),
a redox-sensitive zinc-binding domain (yellow),
and a flexible linker region (green) that serves as
folding sensor in Hsp33. Upon oxidative modifica-
tion of Hsp33’s distal cysteines (Cys265/Cys268),
zinc is released, and Hsp33’s zinc-binding domain
unfolds. This destabilizes the linker region, which
is now in a dynamic equilibrium between the
folded state, in which no thiol oxidation can occur
and an unfolded state, in which oxidative modifi-
cation can occur with a rate constant determined
by the oxidant. Kinetically slow oxidants such as
H2O2 require mild unfolding conditions (e.g.,
heat) to react with the critical cysteine pair
Cys232/Cys234. Kinetically fast oxidants such as
HOCl, however, compete with the refolding reac-
tion and allow oxidation even in the absence of un-
folding conditions. Disulfide bond formation pre-
vents refolding of Hsp33’s redox switch domain
and converts Hsp33 into highly active molecular
chaperone.
over, both DnaK and GroEL fall victim to
oxidative side-chain modifications, which
at least transiently inactivate the proteins
(Khor et al., 2004; Winter et al., 2005). It is
therefore not surprising that bacteria de-
veloped Hsp33 as a highly specialized
chaperone that protects proteins against
aggregation under these specific stress
conditions. It is surprising, however,
how Hsp33 evolved a mechanism that
utilizes as an activator what is so highly
damaging to most other macromole-
cules. In fact, to our knowledge, Hsp33
is only the second class of proteins that is specifically activated
by HOCl. Matrix metalloproteinases (MMP-7, MMP-8, and
MMP-9) were the first proteins discovered to be activated by
low concentrations of HOCl (Fu et al., 2001; Weiss et al., 1985).
Enzymatically inactive MMP-7 contains a central His3-Cys
zinc-binding site. Upon exposure to HOCl, the single cysteine
is oxidized to form either sulfinic or sulfonic acid. This oxidation
exposes the zinc atom and frees the now catalytically active zinc
site to interact with substrates. Increasing HOCl-to-protein ratios
eventually inactivate MMP-7, apparently via the oxidation of
nonactive site residues (Fu et al., 2004). In Hsp33, however,
not even very high HOCl-to-protein ratios (100:1) diminish the
chaperone activity of Hsp33. In contrast, we found that,
in vitro, high concentrations of HOCl induce the formation of
DTT-resistant Hsp33 oligomers that are highly chaperone active
(data not shown). Similar high-activity Hsp33 oligomers have
been observed before when Hsp33 was incubated in 20 mM
H2O2 for 3 hr at 43
C (Akhtar et al., 2004). Although it is unclear
whether these highly active Hsp33 oligomers play any physiolog-
ical role, their in vitro formation illustrates the extreme resistance
of Hsp33 toward HOCl concentrations that unfold, degrade, or
otherwise destroy most other cellular proteins.Cell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc. 699
EXPERIMENTAL PROCEDURES
Strains
The MC4100-derived E. coli strains BB7222, BB7222 hslO::Km (JW176),
BB7224 DrpoH containing an empty pBAD vector, and BB7224 expressing
hslO (Hsp33 gene) under pBAD control (JW49) have been described elsewhere
(Winter et al., 2005). For our studies with V. cholerae, V. cholerae O395 was
used. The hslO deletion strain in V. cholerae O395 (JW371) was constructed
as described in the Supplemental Data.
Materials
Sodium hypochlorite (Sigma-Aldrich), when dissolved in water at pH 7.5, forms
about equal amounts of HOCl and its conjugate base hypochlorite (OCl). We
use the term HOCl to describe this mixture. The precise concentration of HOCl
was determined by absorbance spectroscopy using an extinction coefficient
of 350 M1cm1 at 292 nm and pH 10–12 (Morris, 1966). Nitric oxide solutions
were freshly prepared by dissolving DEANO (Cayman Chemicals, Ann Arbor,
MI) in 10 mM KOH; 4-acetamido-40-maleimidylstilbene-2,20-disulfonic acid
(AMS) and the Isotope Coded Affinity Tag (ICAT) reagents were obtained
from MP Biochemicals (Solon, OH) and Applied Biosystems (Foster City,
CA), respectively.
Oxidation, Reduction, and Chaperone Activity of Hsp33
Reduced, inactive wild-type Hsp33 (from referred to hereafter as Hsp33red)
was purified, reduced, and zinc-reconstituted as described elsewhere (Ilbert
et al., 2007). To oxidize Hsp33, 50 mM Hsp33red was treated with either
2 mM DEANO or 2 mM H2O2 for 3 hr at 30
C or 43C or with 500 mM HOCl
for 20 min at 30C (hereafter called Hsp33HOCl). Then, the oxidants were re-
moved using NAP-5 columns (Amersham Biosciences). To determine activa-
tion kinetics, Hsp33 was incubated in the presence of the indicated oxidants.
At various time points, aliquots were removed, and the influence of Hsp33 on
the aggregation of chemically unfolded citrate synthase (CS, Roche Applied
Sciences) was analyzed at 30C (Ilbert et al., 2007). To test the reversibility
of Hsp33’s activation, 5 mM of Hsp33HOCl was incubated in 5 mM DTT and
5 mM of zinc at 30C. At different time points, aliquots were removed, and
Hsp33’s chaperone activity was determined as before. After incubation for
12 hr at 30C, DTT and zinc were removed by using NAP-5 columns. Hsp33
was concentrated to 50 mM, and activation of Hsp33HOCl0DTT was tested
upon incubation in 500 mM HOCl at 30C or 2 mM H2O2 at 30C or 43C, as
described above. To investigate the influence of Hsp33 on the aggregation
of HOCl-treated CS, 3 mM of CS was incubated in 40 mM potassium phos-
phate (pH 7.5) at 30C and treated with 450 mM HOCl in the absence or pres-
ence of 3 mM Hsp33HOCl. Light scattering was monitored at lex/lem = 360 nm
using a fluorescence spectrophotometer (Hitachi F4500). Detailed protocols
for the structural analysis of Hsp33, GrpE, and CS by circular dichroism
(CD), for monitoring the in vivo and in vitro thiol status of Hsp33 (Graf et al.,
2004) and for determining the molecular mass of Hsp33HOCl using ESI-MS
can be found in the Supplemental Data.
Citrate Synthase Activity
To determine the influence of HOCl and H2O2 on the activity of citrate synthase
(CS), 3 mM CS in 40 mM potassium phosphate (pH 7.5) was treated with
450 mM HOCl or H2O2 at 30
C. After defined time points, aliquots were diluted
1:1000 into assay buffer supplemented with 0.6 mM L-methionine to quench
excess HOCl. Then, CS activity measurements were performed as described
elsewhere (Buchner et al., 1998).
Cultivation of E. coli and V. cholerae Strains and Stress Treatment
To determine the HOCl stress resistance of wild-type and Hsp33 deletion
strains, the strains were cultivated in LB media at 37C until OD600 of 0.5–
0.6 (BB7222 and JW176) or OD600 of 0.3–0.4 (O395 and JW371) was reached.
Then cells were harvested, washed twice using 83 mM sodium phosphate (pH
7.1), and diluted 1:5 into sodium phosphate buffer supplemented with the in-
dicated concentrations of HOCl (Dukan and Touati, 1996). After incubation
for 20 min at 30C in the dark, aliquots were removed, serially diluted in LB me-
dium to quench the remaining HOCl, and spotted onto LB plates. LB plates
were incubated at 30C for 24 hr and the colony-forming units were counted.700 Cell 135, 691–701, November 14, 2008 ª2008 Elsevier Inc.Analysis of Hsp33’s Substrate Specificity In Vivo
To identify aggregation-sensitive proteins in vivo, BB7222, JW176, and the
rpoH deletion strain BB7224 were grown at 30C until midlogarithmic growth.
Then, cultures were split and supplemented with an equal volume of LB me-
dium supplemented with HOCl (final concentration, 6 mM) for HOCl stress
treatment (BB7222, JW176, and BB7224) or shifted to 45C for 30 min for
heat stress treatment (BB7224). At the indicated time points, the cells were
harvested. Isolation of the aggregated proteins, 2D gel electrophoresis, and
data analysis and quantification were performed as described elsewhere
(Winter et al., 2005) (for details see the Supplemental Data).
SUPPLEMENTAL DATA
Supplemental data include two tables, four figures, and Supplemental Exper-
imental Procedures and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(08)01191-4.
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